Back to Royal Bank of Canada Royal Bank of Canada

OCULOCUL

Showing 8 of 28 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Ocular Therapeutix, Inc.

Yes. Royal Bank of Canada holds 62,461 shares of OCUL (Ocular Therapeutix), worth $614,000, as of its Q2 2026 13F filing. It increased the position by 35,907 shares (+135.2%) from Q1 2026. Royal Bank of Canada has held OCUL in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$614,000

Current Shares

62,461

Total Value Change

+$451,000

Total Shares Change

+43,740

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
62,461
+135.2%
$614,0000.0%$9.82
39
2026-Q1
Increased
26,554
+175.1%
$225,0000.0%$8.47
25
2025-Q4
Decreased
9,652
-97.6%
$117,0000.0%$12.14
0
2025-Q3
Increased
395,519
+1.0%
$4.6M0.0%$11.69
27
2025-Q2
Increased
391,754
+144x
$3.6M0.0%$9.28
43
2025-Q1
Decreased
2,709
-55.1%
$20,0000.0%$7.33
0
2024-Q4
Decreased
6,040
-67.7%
$51,0000.0%$8.54
0
2024-Q3
Increased
18,721
+9.1%
$163,0000.0%$8.70
17

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used